Evidence map›Paper›PMID 31264317›Full record

ReviewCell proliferation2019

Overexpression of matrix metalloproteinase-9 in breast cancer cell lines remarkably increases the cell malignancy largely via activation of transforming growth factor beta/SMAD signalling.

Haodi Dong, Hongxiu Diao, Ying Zhao, Huihao Xu, Shimin Pei, Jiafeng Gao, Jie Wang, Tariq Hussain, Deming Zhao, Xiangmei Zhou and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Cell proliferation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 103 citations in OpenAlex.

  1. Review
  2. Targeting PLK1 Reduces MMP10 to Enhance Radiosensitivity in HPV- Head and Neck Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Haodi DongThe Clinical Department, College of Veterinary Medicine, China Agricultural University, Beijing, China.ORCID https://orcid.org/0000-0002-8119-2598
Hongxiu DiaoThe Clinical Department, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Ying ZhaoThe Clinical Department, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Huihao XuThe Clinical Department, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Shimin PeiThe Clinical Department, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Jiafeng GaoThe Clinical Department, College of Veterinary Medicine, China Agricultural University, Beijing, China.ORCID https://orcid.org/0000-0001-7536-7446
Jie WangKey Laboratory of Animal Epidemiology of the Ministry of Agriculture and College of Veterinary Medicine, China Agricultural University, Beijing, China.
Tariq HussainKey Laboratory of Animal Epidemiology of the Ministry of Agriculture and College of Veterinary Medicine, China Agricultural University, Beijing, China.
Deming ZhaoKey Laboratory of Animal Epidemiology of the Ministry of Agriculture and College of Veterinary Medicine, China Agricultural University, Beijing, China.
Xiangmei ZhouKey Laboratory of Animal Epidemiology of the Ministry of Agriculture and College of Veterinary Medicine, China Agricultural University, Beijing, China.
Degui LinThe Clinical Department, College of Veterinary Medicine, China Agricultural University, Beijing, China.
China Agricultural University · CNMinistry of Agriculture · ID

Funding

National Natural Science Foundation of China 31372489National Natural Science Foundation of China 31572578
6 · The paper itself

Abstract

objectivesMatrix metalloproteinase 9 (MMP-9) has been frequently noticed in the breast cancers. In this study, we aim to investigate the associations of MMP-9 with the activation of transforming growth factor beta (TGF-β)/SMAD signalling and the malignancy of breast malignant tumour cells. MATERIALS AND

methodsThe distributions of MMP-9 and TGF-β in the tissues of canine breast cancers were screened by immunohistochemical assays. A recombinant plasmid expressing mouse MMP-9 was generated and transiently transfected into three different breast cancer cell lines. Cell Counting Kit-8 and colony formation assay were used to study cell viability. Migration and invasion ability were analysed by wound assay and transwell filters. Western blot and quantitative real-time PCR were used to determine the protein and mRNA expression.

resultRemarkable strong MMP-9 and TGF-β signals were observed in the malignant tissues of canine breast cancers. In the cultured three cell lines receiving recombinant plasmid expressing mouse MMP-9, the cell malignancy was markedly increased, including the cell colony formation, migration and epithelial-mesenchymal transition. The levels of activated TGF-β, as well as SMAD4, SMAD2/3 and phosphorylation of SMAD2, were increased, reflecting an activation of TGF-β/SMAD signalling. We also demonstrated that the inhibitors specific for MMP-9 and TGF-β sufficiently blocked the overexpressing MMP-9 induced the activation of SMAD signalling and enhancement on invasion in the tested breast cancer cell lines.

conclusionOverexpression of MMP-9 increases the malignancy of breast cancer cell lines, largely via activation of the TGF-β/SMAD signalling.

Indexed as

Breast NeoplasmsEpithelial-Mesenchymal TransitionFemaleHumansMatrix Metalloproteinase 9PhosphorylationSignal TransductionSmad ProteinsTransforming Growth Factor betaMatrix Metalloproteinase 9Smad ProteinsTransforming Growth Factor betacanine breast cancerinvasionmalignancyMMP-9TGF-β/SMAD signalling

Identifiers

PMID31264317
PMCPMC6797518
OpenAlexW2954941941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.